Rescinnamine

DB01180

small molecule approved

Deskripsi

Rescinnamine is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug. It is an alkaloid obtained from Rauwolfia serpentina and other species of Rauwolfia.

Struktur Molekul 2D

Berat 634.716
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

836 Data
Alfuzosin Alfuzosin may increase the hypotensive activities of Rescinnamine.
Amifostine Rescinnamine may increase the hypotensive activities of Amifostine.
Diazoxide Diazoxide may increase the hypotensive activities of Rescinnamine.
Methylphenidate Methylphenidate may decrease the antihypertensive activities of Rescinnamine.
Dexmethylphenidate Dexmethylphenidate may decrease the antihypertensive activities of Rescinnamine.
Obinutuzumab Rescinnamine may increase the hypotensive activities of Obinutuzumab.
Pentoxifylline Pentoxifylline may increase the hypotensive activities of Rescinnamine.
Rituximab Rescinnamine may increase the hypotensive activities of Rituximab.
Angiotensin 1-7 Rescinnamine may decrease the antihypertensive activities of Angiotensin 1-7.
Yohimbine Yohimbine may decrease the antihypertensive activities of Rescinnamine.
Epicaptopril Epicaptopril may decrease the antihypertensive activities of Rescinnamine.
Siponimod Siponimod may decrease the antihypertensive activities of Rescinnamine.
Reserpine Rescinnamine may decrease the antihypertensive activities of Reserpine.
Torasemide Rescinnamine may decrease the antihypertensive activities of Torasemide.
Nitroprusside Rescinnamine may decrease the antihypertensive activities of Nitroprusside.
Minoxidil Rescinnamine may decrease the antihypertensive activities of Minoxidil.
Clozapine Clozapine may decrease the antihypertensive activities of Rescinnamine.
Imipramine Imipramine may decrease the antihypertensive activities of Rescinnamine.
Chlorpromazine Chlorpromazine may decrease the antihypertensive activities of Rescinnamine.
Doxazosin Rescinnamine may decrease the antihypertensive activities of Doxazosin.
Dexmedetomidine Dexmedetomidine may decrease the antihypertensive activities of Rescinnamine.
Mecamylamine Rescinnamine may decrease the antihypertensive activities of Mecamylamine.
Thioridazine Thioridazine may decrease the antihypertensive activities of Rescinnamine.
Phentolamine Phentolamine may decrease the antihypertensive activities of Rescinnamine.
Sufentanil Sufentanil may decrease the antihypertensive activities of Rescinnamine.
Nitroglycerin Rescinnamine may decrease the antihypertensive activities of Nitroglycerin.
Isoflurane Isoflurane may decrease the antihypertensive activities of Rescinnamine.
Tolazoline Tolazoline may decrease the antihypertensive activities of Rescinnamine.
Fenoldopam Rescinnamine may decrease the antihypertensive activities of Fenoldopam.
Propofol Propofol may decrease the antihypertensive activities of Rescinnamine.
Remifentanil Remifentanil may decrease the antihypertensive activities of Rescinnamine.
Phenoxybenzamine Phenoxybenzamine may decrease the antihypertensive activities of Rescinnamine.
Methyldopa Rescinnamine may decrease the antihypertensive activities of Methyldopa.
Guanfacine Guanfacine may decrease the antihypertensive activities of Rescinnamine.
Bretylium Rescinnamine may decrease the antihypertensive activities of Bretylium.
Halothane Halothane may decrease the antihypertensive activities of Rescinnamine.
Terazosin Rescinnamine may decrease the antihypertensive activities of Terazosin.
Desflurane Desflurane may decrease the antihypertensive activities of Rescinnamine.
Bromocriptine Bromocriptine may decrease the antihypertensive activities of Rescinnamine.
Sevoflurane Sevoflurane may decrease the antihypertensive activities of Rescinnamine.
Clomipramine Clomipramine may decrease the antihypertensive activities of Rescinnamine.
Hydralazine Rescinnamine may decrease the antihypertensive activities of Hydralazine.
Lofexidine Rescinnamine may decrease the antihypertensive activities of Lofexidine.
Rotigotine Rotigotine may decrease the antihypertensive activities of Rescinnamine.
Riociguat Rescinnamine may decrease the antihypertensive activities of Riociguat.
Isoxsuprine Isoxsuprine may decrease the antihypertensive activities of Rescinnamine.
Indoramin Rescinnamine may decrease the antihypertensive activities of Indoramin.
Moxonidine Rescinnamine may decrease the antihypertensive activities of Moxonidine.
Selpercatinib Selpercatinib may decrease the antihypertensive activities of Rescinnamine.
Naxitamab Naxitamab may decrease the antihypertensive activities of Rescinnamine.
Levamlodipine Rescinnamine may decrease the antihypertensive activities of Levamlodipine.
Amphetamine Amphetamine may decrease the antihypertensive activities of Rescinnamine.
Aliskiren The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Rescinnamine.
Allopurinol The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Rescinnamine.
Aprotinin Aprotinin may decrease the antihypertensive activities of Rescinnamine.
Azathioprine The risk or severity of myelosuppression, anemia, and severe leukopenia can be increased when Rescinnamine is combined with Azathioprine.
Ertugliflozin The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Ertugliflozin is combined with Rescinnamine.
Canagliflozin The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Rescinnamine.
Dapagliflozin The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Dapagliflozin is combined with Rescinnamine.
Empagliflozin The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Rescinnamine.
Dapoxetine Dapoxetine may increase the orthostatic hypotensive activities of Rescinnamine.
Drospirenone Rescinnamine may increase the hyperkalemic activities of Drospirenone.
Eplerenone Eplerenone may increase the hyperkalemic activities of Rescinnamine.
Everolimus The risk or severity of adverse effects can be increased when Everolimus is combined with Rescinnamine.
Sirolimus The risk or severity of adverse effects can be increased when Sirolimus is combined with Rescinnamine.
Semuloparin The risk or severity of hyperkalemia can be increased when Rescinnamine is combined with Semuloparin.
Icatibant Icatibant may decrease the antihypertensive activities of Rescinnamine.
Lithium citrate The serum concentration of Lithium citrate can be increased when it is combined with Rescinnamine.
Lithium carbonate The serum concentration of Lithium carbonate can be increased when it is combined with Rescinnamine.
Lithium hydroxide The serum concentration of Lithium hydroxide can be increased when it is combined with Rescinnamine.
Tizanidine The risk or severity of hypotension can be increased when Tizanidine is combined with Rescinnamine.
Tolvaptan Tolvaptan may increase the hyperkalemic activities of Rescinnamine.
Trimethoprim Trimethoprim may increase the hyperkalemic activities of Rescinnamine.
Desmopressin Desmopressin may decrease the antihypertensive activities of Rescinnamine.
Phentermine Phentermine may decrease the antihypertensive activities of Rescinnamine.
Midodrine Midodrine may decrease the antihypertensive activities of Rescinnamine.
Eletriptan Eletriptan may decrease the antihypertensive activities of Rescinnamine.
Isoetharine Isoetharine may decrease the antihypertensive activities of Rescinnamine.
Methysergide Methysergide may decrease the antihypertensive activities of Rescinnamine.
Cabergoline Cabergoline may decrease the antihypertensive activities of Rescinnamine.
Atomoxetine Atomoxetine may decrease the antihypertensive activities of Rescinnamine.
Etomidate Etomidate may decrease the antihypertensive activities of Rescinnamine.
Zolmitriptan Zolmitriptan may decrease the antihypertensive activities of Rescinnamine.
Dihydroergotamine Dihydroergotamine may decrease the antihypertensive activities of Rescinnamine.
Amitriptyline Amitriptyline may decrease the antihypertensive activities of Rescinnamine.
Protriptyline Protriptyline may decrease the antihypertensive activities of Rescinnamine.
Methylergometrine Methylergometrine may decrease the antihypertensive activities of Rescinnamine.
Norepinephrine Norepinephrine may decrease the antihypertensive activities of Rescinnamine.
Mirtazapine Mirtazapine may decrease the antihypertensive activities of Rescinnamine.
Phenylephrine Phenylephrine may decrease the antihypertensive activities of Rescinnamine.
Phenylpropanolamine Phenylpropanolamine may decrease the antihypertensive activities of Rescinnamine.
Promazine Promazine may decrease the antihypertensive activities of Rescinnamine.
Droperidol Droperidol may decrease the antihypertensive activities of Rescinnamine.
Buspirone Buspirone may decrease the antihypertensive activities of Rescinnamine.
Nortriptyline Nortriptyline may decrease the antihypertensive activities of Rescinnamine.
Amoxapine Amoxapine may decrease the antihypertensive activities of Rescinnamine.
Doxapram Doxapram may decrease the antihypertensive activities of Rescinnamine.
Atropine Atropine may decrease the antihypertensive activities of Rescinnamine.
Lisuride Lisuride may decrease the antihypertensive activities of Rescinnamine.
Metaraminol Metaraminol may decrease the antihypertensive activities of Rescinnamine.

Target Protein

Angiotensin-converting enzyme ACE

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 1
International Brands
  • Tsuruselpi S

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul